Drug-eluting stents for the treatment of in-stent restenosis - 'real world' double centre experience in consecutive patients

International Journal of Cardiovascular Interventions

Volumn 7, Issue 4, 2005, Pages 188-192

  Anderson, Richard A ^a   Fath Ordoubadi, Farzin ^b   Younas, Sheraz ^b   Bainbridge, Anthony ^b   Swallow, Rosie A ^c   Dawkins, Keith D ^c   Curzen, Nicholas P ^c  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Carotid interventions; Distal embilization; Filter; Percutaneous interventons

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; METAL; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DRUG ELUTING STENT; EVALUATION; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; PROSTHESIS DESIGN; RECURRENCE; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 29744437677     PISSN: 14628848     EISSN: 14711796     Source Type: Journal    
DOI: 10.1080/14628840500466687     Document Type: Article

References (22)

1. Lowe HC, Osterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol. 2002;39:183-93.
2. Babapule MN, Eisenberg MJ. Coated stents for the prevention of restenosis: Part I. Circulation. 2002;106:2734-40.
3. Babapule MN, Eisenberg MJ. Coated stents for the prevention of restenosis: Part II. Circulation. 2002;106:2859-66.
4. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation. 1996;94:398-400.
5. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38-42.
6. Colombo A, Drzewield J, Banning A, et al., TAXUS II Study Group. Randomised study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-94.
7. Morice MC, Serruys PW, Sousa JE, et al., RAVEL Study Group. Randomized Study with the sirolimus-coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. N Engl J Med. 2002;346:1773-80.
8. Mose JW, Leon MB, Popma JJ, et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.
9. Bauters C, Banos J-L, Belle E, et al. Six month angiographic outcome after successful repeat PCI for in-stent restenosis. Circulation. 1998;97:318-21.
10. Chua DC, Almeda FQ, Senter S, et al. Predictors of late cardiac events following treatment with SR-90 beta-irradiation for instent restenosis. Cardivasc Radiat Med. 2003;4:7-11.
11. Degertekin M, Lemos PA, Lee CH, et al. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. Eur Heart J. 2004;25:32-8.
12. Lemos PA, Lee CH, Sianos G, et al. Sirolimus-Eluting Stent Implantation in the "Real-World": Initial Results of the RESEARCH Registry. Am J Cardiol. 2002;90:6H.
13. Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: instent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation. 2003;107:559-64.
14. Tanabe K, Serruys PW, Grube E, et al. TAXUS III Trial: instent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation. 2003;107:559-64.
15. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2003;107:24-7.
16. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol. 2003;41:184-9.
17. Saia F, Lemos , Arampatzis CA, et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis:insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. Heart. 2004;90:1183-8.
18. Werner GS, Emig U, Krack A, Schwarz G, Figulla HR. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis. Cath Cardiovasc Interv. 2004;63:259-64.
19. Saia F, Lemos PA, Sianos G, et al. Effectiveness of sirolimus-eluting stent implantation for recurrent instent restenosis after brachtherapy. Am J Cardiol. 2003;92:200-3.
20. Mauri L, O'Malley AJ, Cutlip DE, et al. Effects of stent length and lesion length on coronary restenosis. Am J Cardiol. 2004;93:1340-6.
21. Saia F, Lemos , Arampatzis CA, et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis:insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. Heart. 2004;90:1183-8.
22. Kastrati A, Mehilli J, von Beckerath N, et al. ISAR-DESIRE study investigators. JAMA. 2005;293:165-71.